98 results on '"Thyssen, Jacob P"'
Search Results
2. The burden of head-and-neck dermatitis in adults with atopic dermatitis and its association with asthma, rhinitis, and disease severity
3. Adverse events from topical corticosteroid use in chronic hand eczema — Findings from the Danish Skin Cohort
4. Characteristics and drivers of fatigue in patients with psoriasis and psoriatic arthritis – a cross sectional study
5. The Proteome of Hand Eczema Assessed by Tape Stripping
6. Similar Skin Barrier Function in Persons with Type 1 Diabetes Compared with Healthy Controls
7. Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study
8. Comorbidities of atopic dermatitis—what does the evidence say?
9. Drug survival of adalimumab, secukinumab, and ustekinumab in psoriasis as determined by either dose escalation or drug discontinuation during the first 3 years of treatment – a nationwide cohort study
10. Reduced skin microbiome diversity in infancy is associated with increased risk of atopic dermatitis in high-risk children
11. The optimal biologic treatment target for hidradenitis suppurativa remains undiscovered
12. Long-term disease control in atopic dermatitis using biologics
13. A Skin Care Program to Prevent Skin Problems Due to Diabetes Devices in Children and Adolescents: A Cluster-Controlled Intervention Study
14. Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies
15. Skin TARC/CCL17 increase precedes the development of childhood atopic dermatitis
16. 33233 Long-term efficacy (to 68 weeks) of baricitinib in adult patients with moderate to severe atopic dermatitis (AD) who were treatment responders or partial responders and originally included in the combination topical corticosteroids study BREEZE-AD7
17. Biological therapy for young children with atopic dermatitis
18. 34358 Long-term efficacy of dupilumab in adults with moderate-to-severe atopic dermatitis (AD): Results from an open-label extension (OLE) trial up to 4 years
19. 32496 Efficacy and safety of abrocitinib according to geographies
20. 34599 Achieving incrementally greater skin improvement thresholds with upadacitinib versus dupilumab in moderate-to-severe atopic dermatitis (AD): Heads Up study results
21. Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial
22. Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries
23. Disease burden, symptoms, and use of analgesics in patients with psoriasis with or without psoriatic arthritis: A cross-sectional study
24. Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic Review
25. The risk of COVID-19 infection in patients with atopic dermatitis: A retrospective cohort study
26. 27603 Rapid itch relief with abrocitinib predicts later skin clearance: A post hoc analysis vs dupilumab and placebo in JADE COMPARE
27. 28032 Rapid itch improvement with upadacitinib with or without concomitant topical corticosteroids (TCS) in moderate-to-severe atopic dermatitis (AD): Results from 3 phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)
28. 25442 Relationship between topical corticosteroid utilization and atopic dermatitis severity and burden: A population-based cross-sectional study
29. 25532 Effects of upadacitinib on patient-reported symptoms of atopic dermatitis: Atopic Dermatitis Symptom Scale (ADerm-SS) results from two pivotal phase 3 studies (MEASURE UP 1 and MEASURE UP 2)
30. 27533 Comparative efficacy and safety of systemic therapies used in adult and adolescent moderate-to-severe atopic dermatitis (AD): A systematic literature review (SLR) and network meta-analysis (NMA)
31. 26292 Rapid improvement in skin pain, and its impact on quality of life, in adult patients with moderate-to-severe atopic dermatitis from a double-blind, placebo-controlled baricitinib phase 3 study
32. 27489 Depth of response to abrocitinib in adults with moderate-to-severe atopic dermatitis (AD): Pooled analysis of monotherapy studies
33. 27237 Effect of abrocitinib vs dupilumab and placebo on patient-reported outcomes (PROs) in moderate-to-severe atopic dermatitis (AD) in JADE COMPARE
34. Bidirectional association between atopic dermatitis, conjunctivitis, and other ocular surface diseases: A systematic review and meta-analysis
35. Chemicals in moisturizers may promote type 2 inflammation and food allergy
36. Rhinitis prevalence and association with atopic dermatitis
37. Infusion of Pituitary Adenylate Cyclase–Activating Polypeptide-38 in Patients with Rosacea Induces Flushing and Facial Edema that Can Be Attenuated by Sumatriptan
38. Treatment of atopic dermatitis with biologics and Janus kinase inhibitors
39. Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council
40. Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect
41. Risk of systemic infections in adults with atopic dermatitis: A nationwide cohort study
42. Prevalence of asthma in patients with atopic dermatitis: A systematic review and meta-analysis
43. The stratum corneum transcriptome in atopic dermatitis can be assessed by tape stripping
44. Abrocitinib for atopic dermatitis – Authors' reply
45. Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis
46. 18856 The association between atopic dermatitis and hypertension: A systematic review and meta-analysis
47. Side effects after artificial hair implants: 2 case reports
48. Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
49. How does parental history of atopic disease predict the risk of atopic dermatitis in a child? A systematic review and meta-analysis
50. Filaggrin Expression and Processing Deficiencies Impair Corneocyte Surface Texture and Stiffness in Mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.